메뉴 건너뛰기




Volumn 38, Issue 5, 2001, Pages 1074-1081

Lamivudine is effective for the treatment of reactivation of hepatitis b virus and fulminant hepatic failure in renal transplant recipients

Author keywords

Fulminant hepatic failure; Hepatitis B virus (HBV); Hepatitis B virus (HBV) DNA; Lamivudine; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

EID: 0034748142     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.28607     Document Type: Article
Times cited : (63)

References (34)
  • 33
    • 0032869876 scopus 로고    scopus 로고
    • Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B
    • (1999) Hepatology , vol.30 , pp. 770-774
    • Chien, R.N.1    Liaw, Y.F.2    Atkins, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.